Albert B. Chandler Medical Center, University of Kentucky
Lexington, Kentucky, United States
Hospital in Lexington, Kentucky
800 Rose St, Lexington, KY 40536
945 Beds
About Albert B. Chandler Medical Center, University of Kentucky
Opened in 1962, the Albert B. Chandler Hospital along Rose Street at the University of Kentucky in Lexington, Kentucky is the flagship component of UK HealthCare. It is named for twice-former Governor of Kentucky A. B. "Happy" Chandler.
There are 945 beds in Albert B. Chandler Medical Center, University of Kentucky.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
52
Radiation Therapy Oncology Group
36
Gynecologic Oncology Group
32
Children's Oncology Group
9
Eastern Cooperative Oncology Group
5
Alliance for Clinical Trials in Oncology
4
National Cancer Institute (NCI)
4
University of Kentucky
4
Gerald Supinski
3
Pfizer
3
Shire
3
Clinical Trials at Albert B. Chandler Medical Center, University of Kentucky
During the past decade, Albert B. Chandler Medical Center, University of Kentucky conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 20 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
Completed
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
Completed
1,250
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
1993-06-01
Terminated
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
1992-05-01
Completed
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
1996-12-01
Completed
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
1994-02-01
Completed
200
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
1994-03-01
2004-08-01
Completed
25
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Albert B. Chandler Medical Center, University of Kentucky" #1 sponsor was "SWOG Cancer Research Network" with 52 trials, followed by "Radiation Therapy Oncology Group" with 36 trials
sponsored, "Gynecologic Oncology Group" with 32 trials sponsored, "Children's Oncology Group" with 9 trials sponsored and "Eastern Cooperative Oncology Group"
with 9 trials sponsored. Other sponsors include 78 different institutions and
companies that sponsored additional 62 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Albert B. Chandler Medical Center, University of Kentucky"
#1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 22 trials.
Clinical Trials Conditions at Albert B. Chandler Medical Center, University of Kentucky
According to Clinical.Site data, the most researched conditions in "Albert B. Chandler Medical Center, University of Kentucky" are
"Ovarian Cancer" (18 trials), "Lung Cancer" (16 trials), "Head and Neck Cancer" (15 trials), "Leukemia" (15 trials) and "Lymphoma" (12 trials). Many other conditions were trialed in "Albert B. Chandler Medical Center, University of Kentucky" in a lesser frequency.
Clinical Trials Intervention Types at Albert B. Chandler Medical Center, University of Kentucky
Most popular intervention types in "Albert B. Chandler Medical Center, University of Kentucky" are "Drug" (177 trials), "Radiation" (54 trials), "Procedure" (44 trials), "Biological" (38 trials) and "Other" (7 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (45 trials), "cisplatin" (30 trials), "paclitaxel" (25 trials), "filgrastim" (23 trials) and "cyclophosphamide" (18 trials). Other intervention names were less common.
Clinical Trials Genders at Albert B. Chandler Medical Center, University of Kentucky
The vast majority of trials in "Albert B. Chandler Medical Center, University of Kentucky" are
163 trials for "All" genders, 47 trials for "Female" genders and 7 trials for "Male" genders.
Clinical Trials Status at Albert B. Chandler Medical Center, University of Kentucky
Currently, there are NaN active trials in "Albert B. Chandler Medical Center, University of Kentucky".
undefined are not yet recruiting,
14 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 158 completed trials in Albert B. Chandler Medical Center, University of Kentucky,
undefined suspended trials,
and 33 terminated clinical trials to date.
Out of the total trials that were conducted in Albert B. Chandler Medical Center, University of Kentucky, 19 "Phase 1"
clinical trials were conducted, 111 "Phase 2" clinical
trials and 77 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 13 trials that are defined as “Not Applicable".